Healthcare Glob. Ent. Ltd Right History

Healthcare Glob. Ent. Ltd has announced 1 rights issues since 29 Aug, 2023, with the most recent issue declared on Feb 17, 2026 in the ratio of 1:17 at a price of ₹10 per share.

₹575.65₹575.65+1.05 (0.18%)

Last updated on 01 Mar, 2026 | 21:22 IST

Healthcare Glob. Ent. Rights Issue Details

Rights Ratio	Face Value	Premium	Ex-Right Date	Record Date	Announcement Date
1:17	10	502.00	02-03-2026	02-03-2026	17-02-2026

*Disclaimer: The information listed is solely for research purposes and are not recommendations. Please conduct your own research before making any investment decisions.

FAQs

Who is eligible to apply for Healthcare Global Enterprises rights issue?

Existing shareholders of Healthcare Global Enterprises as of the record date are eligible to participate in a rights issue allowing them to purchase additional shares often at a discount.

How can existing shareholders apply for Healthcare Global Enterprises rights issue?

Shareholders can apply for Healthcare Global Enterprises rights issue by following the company instructions, typically by submitting an application form and making the payment within the specified period.

Is the rights issue of Healthcare Global Enterprises mandatory for existing shareholders?

No! Participation in Healthcare Global Enterprises rights issue is not mandatory, but voluntary. However, shareholders can choose to exercise their rights, sell them, or let them expire.

Has Healthcare Global Enterprises announced any rights issues in the past?

Healthcare Global Enterprises did not have any rights issues in the last 2023-2025 but there is an upcoming rights issue on 02-03-2026 in the ratio 1:17

What was the last rights issue price and ratio for Healthcare Global Enterprises?

There has been no rights issue for Healthcare Global Enterprises in the last 2023-2025. However, there is an upcoming rights issue on record date: 02-03-2026 for issue price of 512.00 and rights ratio of 1:17

Healthcare Glob Ent Ltd Rights Issue

Attention Investors & Disclaimer

Upstox Securities Pvt. Ltd.: SEBI Registration No. INZ000315837 | NSE TM Code: 13942 | BSE TM Code: 6155 | MCX TM Code: 46510 | CDSL Reg No.: IN-DP-761-2024 | CIN: U65100DL2021PTC376860 | Compliance Officer: Mr. Kapil Jaikalyani. Tel No.: (022) 24229920. Email ID: compliance@upstox.com | Registered Address: 809, New Delhi House, Barakhamba Road, Connaught Place, New Delhi - 110001 | Correspondence Address: 30th Floor, Sunshine Tower, Senapati Bapat Marg, Dadar (West), Mumbai - 400013. | For any complaints, email at complaints@upstox.com and complaints.mcx@upstox.com.

About the Company

Upstox Securities Private Limited is a wholly owned subsidiary of RKSV Securities India Private Limited.

SEBI Scores

Procedure to file a complaint on SEBI SCORES: Register on the SCORES portal. Mandatory details for filing complaints on SCORES include: Name, PAN, Address, Mobile Number, and E-mail ID. Benefits include effective communication and speedy redressal of grievances. Please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI, along with our Terms of Use and Privacy Policy.

Attention to Investors

Smart Online Dispute Resolution: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies.

Collateral: Clearing Corporation has provided a web based facility that allows clients to view their disaggregated collateral placed. Please access them via these links NCL | ICCL

Kindly refer to the Advisory Guidelines issued by Exchanges for trading

Investment Disclaimer

Disclaimer: Investments in the securities market are subject to market risks, read all the related documents carefully before investing.

*Brokerage will not exceed the SEBI prescribed limit and Annual Maintenance charges are free upto one year for users onboarded from 14-Feb-2025 onwards

We do not authorize any person or organization to conduct trades on behalf of Upstox customers. If you find anyone claiming to be part of Upstox or RKSV or representing Upstox/RKSV and offering such services, please send us an email at complaints@upstox.com

Use of New Validated UPI Handles in the Securities Market | CDSL voting on motions moved by Listed Companies

Insurance

RKSV Securities India Pvt. Ltd. ("Upstox") with registered office at 807, New Delhi House Barakhamba Road Connaught Place, New Delhi, Delhi-110001, Delhi (CIN: U74900DL2009PTC189166) is a Corporate Agent registered with Insurance Regulatory and Development Authority of India (IRDAI) (Category: Composite, IRDAI Regn No.-: CA0918 valid till 05-03-2027).

Disclosures/Disclaimers for Insurance Products

Email ID: insurancesupport@rksv.in

Bima Bharosa Portal: https://bimabharosa.irdai.gov.in/

IRDAI: https://irdai.gov.in/

Insurance Ombudsman: https://www.cioins.co.in/